<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575509</url>
  </required_header>
  <id_info>
    <org_study_id>MAVI</org_study_id>
    <nct_id>NCT01575509</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects</brief_title>
  <official_title>A Clinical, Randomized, Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Life Sciences Ltd.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kiantama Oy</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Suomen Sokeri Oy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Life Sciences Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the 2 hour glycemic responses of two bread products and one
      dried lingonberry product. The average postprandial response of each product is compared with
      glycemic response after ingestion of control solution with a similar carbohydrate content
      (glucose, glucose-fructose) as the provided by the respective test product.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The 2 hours glycemic responses to test products and control solutions</measure>
    <time_frame>2 hours</time_frame>
    <description>Capillary blood samples are taken before and at 15, 30, 45, 60, 90 and 120 min after starting to eat the test products or control solutions for measurements of plasma glucose concentrations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The 2 hours insulinemic responses to dried lingonberry product and corresponding control solution</measure>
    <time_frame>2 hours</time_frame>
    <description>Capillary blood samples are collected before and at 15, 30, 45, 60, 90 and 120 min after eating the lingonberry test product and glucose-fructose control solution. The serum insulin concentrations are analysed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incremental area under glucose curve (IAUC) of bread test products</measure>
    <time_frame>2 hours</time_frame>
    <description>IAUC (mmol/l x min) is determined using the trapezoidal method for each subject and bread test product and corresponding glucose control solution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic index (GI) of bread test products</measure>
    <description>The GI is calculated as a percentage of the glucose IAUC values of a bread product and a glucose control solution.</description>
  </secondary_outcome>
  <enrollment type="Actual">14</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Berry product</intervention_name>
    <description>Sugar infused dried lingonberry</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bread product</intervention_name>
    <description>Brown bread</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bread product</intervention_name>
    <description>Whole grain bread</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose control solution</intervention_name>
    <description>Glucose solution with a corresponding amount of carbohydrates as provided by the bread test products</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose-fructose control solution</intervention_name>
    <description>Control solution with a similar carbohydrate content as provided by the dried lingonberry test product</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  voluntary given written concent for participation in research

          -  healthy man or woman, age between 18 and 65 years

          -  regular eating

          -  Body Mass Index 18,5 - 29,9 kg/m2

        Exclusion Criteria:

          -  diabetes

          -  gastrointestinal diseases

          -  hepatic, kidney, pancreas or thyroid disease or disorder

          -  arthritis

          -  pregnancy or breast feeding

          -  smoking

          -  allergy

          -  severe diseases

          -  blood donation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PÃ¤ivi Cheney, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Life Sciences Ltd</name>
      <address>
        <city>Kajaani</city>
        <zip>87100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2012</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>June 14, 2012</last_update_submitted>
  <last_update_submitted_qc>June 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

